Compass Passways WKN: A2QCDR ISIN: US20451W1018 Kürzel: CMPS Forum: Aktien User: OnkelDagobert69

https://beststocks.com/compass-pathways-receives-positive-outlook-fr/

https://www.globenewswire.com/news-release/2023/07/05/2699413/0/en/COMPASS-Pathways-Secures-Term-Loan-Facility-for-Up-to-50-Million-from-Hercules-Capital.html

https://www.globenewswire.com/news-release/2023/02/28/2616859/0/en/COMPASS-Pathways-Announces-Fourth-Quarter-and-Year-End-2022-Financial-Results-and-Business-Highlights.html

Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far https://www.benzinga.com/amp/content/30045488 Mental health care company COMPASS Pathways plc (NASDAQ:CMPS) has announced positive data demonstrating the potential of its proprietary synthetic psilocybin compound COMP360 in treating depression within Type II bipolar disorder. Presented at the American College of Neuropsychopharmacology’s annual meeting, the early yet positive results correspond to an investigator-initiated, open-label pilot study assessing safety and efficacy of a single 25 mg dose of COMP360 in 14 participants with type II bipolar disorder depression.  ... Run by Dr. Scott Aaronson at Sheppard Pratt Baltimore, the Type II bipolar disorder clinical trial found that 86% -or 12 out of 14- of the participants met response and remission criteria for the Montgomery-Åsberg Depression Rating Scale (MADRS) at 12 weeks after psilocybin administration.  As for other measures, no increase in the suicidality score based on the MADRS was shown, nor manic symptoms or unexpected adverse events or difficulties with the dosing sessions were reported throughout the study. Dr. Aaronson said that it is really encouraging to see almost 90% of participants go into remission for three months given this condition’s extreme difficulty in being treated, and that now these findings ought to be validated in larger studies. ...

https://www.globenewswire.com/news-release/2022/11/03/2547393/0/en/COMPASS-Pathways-Announces-Third-Quarter-2022-Financial-Results-and-Business-Highlights.html COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Und ich gratuliere Plankton natürlich zu seinem aktuellen Gewinn von ca. 95 Euro, 👍👍👍👍

Sorry RexBest, die Aussage war nicht böse gemeint, bin hier schon lange investiert und deutlich im Minus, aber ich glaube an den Wert und das Thema, aktuell spricht ja wieder einiges für einen längerfristigen Erfolg. Insofern allen Investierten Gute Erträge. 👍👍👍

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights https://www.globenewswire.com/news-release/2022/08/04/2492136/0/en/COMPASS-Pathways-plc-announces-second-quarter-2022-financial-results-and-business-highlights.html

War ja nen guter Kauf, hoffe du hast mitgerechnet dannhaltnet :)

Bin auch reingegangen seh das Ganze wie Plankton - ein mehr als interessanter Zock

Dannhaltnet du hast ne Menge Karma minus gemacht

Plankton, Du hast aktuell 261 Euro miese gemacht :-)

https://www.globenewswire.com/news-release/2022/05/10/2439493/0/en/COMPASS-Pathways-plc-announces-first-quarter-2022-financial-results-and-business-highlights.html

Hab schon genug Geld hier versenkt. Trotzdem glaube ich das das nochmal was wird. Bin momentan nicht mehr investiert. Habe es aber noch auf dem Schirm.

Kann ich den Totalverlust besser verschmerzen

Warum nicht 200 stk?